[{"arm_notes": "", "treatment_id": null, "treatment_name": "Group A (low dose in younger adults):LYB001: placebo=4:1; three dose at day 0; 28; 56;Group B (high dose in younger adults):LYB001: placebo=4:1; three dose at day 0; 28; 56;Group C (low dose in older adults):LYB001: placebo=4:1; three dose at day 0; 28; 56;Group D (high dose in older adults):LYB001: placebo=4:1; three dose at day 0; 28; 56;", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Group A (low dose in younger adults):LYB001: placebo=4:1; three dose at day 0; 28; 56", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Group B (high dose in younger adults):LYB001: placebo=4:1; three dose at day 0; 28; 56", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Group C (low dose in older adults):LYB001: placebo=4:1; three dose at day 0; 28; 56", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Group D (high dose in older adults):LYB001: placebo=4:1; three dose at day 0; 28; 56;", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "low dose in younger adults", "treatment_id": 2067, "treatment_name": "Lyb001", "treatment_type": "Virus-like particle", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "high dose in younger adults)", "treatment_id": 2067, "treatment_name": "Lyb001", "treatment_type": "Virus-like particle", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "low dose in older adults", "treatment_id": 2067, "treatment_name": "Lyb001", "treatment_type": "Virus-like particle", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "high dose in older adults", "treatment_id": 2067, "treatment_name": "Lyb001", "treatment_type": "Virus-like particle", "pharmacological_treatment": "Vaccine"}]